BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34855875)

  • 1. Treatment, recurrence rates and follow-up of Tenosynovial Giant Cell Tumor (TGCT) of the foot and ankle-A systematic review and meta-analysis.
    Siegel M; Bode L; Südkamp N; Kühle J; Zwingmann J; Schmal H; Herget GW
    PLoS One; 2021; 16(12):e0260795. PubMed ID: 34855875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Tenosynovial Giant Cell Tumor of the Foot and Ankle.
    Barnett JR; Rudran B; Khan A; O'Reilly-Harbidge S; Patel S; Malhotra K; Cullen N; Welck M; Aston W
    Foot Ankle Int; 2023 Oct; 44(10):1013-1020. PubMed ID: 37644900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distraction arthroplasty combined with autologous bone grafting for diffuse-type tenosynovial giant cell tumour with articular cartilage defect and subchondral bone cysts: A case report.
    Ikuta Y; Nakasa T; Sumii J; Nekomoto A; Kawabata S; Adachi N
    Mod Rheumatol Case Rep; 2023 Jun; 7(2):483-487. PubMed ID: 36484489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of tenosynovial giant cell tumour of the foot and ankle.
    Spierenburg G; Lancaster ST; van der Heijden L; Mastboom MJL; Gelderblom H; Pratap S; van de Sande MAJ; Gibbons CLMH
    Bone Joint J; 2021 Apr; 103-B(4):788-794. PubMed ID: 33789469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study.
    Mastboom MJL; Palmerini E; Verspoor FGM; Rueten-Budde AJ; Stacchiotti S; Staals EL; Schaap GR; Jutte PC; Aston W; Gelderblom H; Leithner A; Dammerer D; Takeuchi A; Thio Q; Niu X; Wunder JS; ; van de Sande MAJ
    Lancet Oncol; 2019 Jun; 20(6):877-886. PubMed ID: 31029509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenosynovial giant cell tumor in the foot and ankle.
    Çevik HB; Kayahan S; Eceviz E; Gümüştaş SA
    Foot Ankle Surg; 2020 Aug; 26(6):712-716. PubMed ID: 31526689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenosynovial Giant Cell Tumors in Children: A Similar Entity Compared With Adults.
    Mastboom MJL; Verspoor FGM; Uittenbogaard D; Schaap GR; Jutte PC; Schreuder HWB; van de Sande MAJ
    Clin Orthop Relat Res; 2018 Sep; 476(9):1803-1812. PubMed ID: 29494352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Treatment of Localized-Type Tenosynovial Giant Cell Tumors of Large Joints: A Study Based on a Multicenter-Pooled Database of 31 International Sarcoma Centers.
    Mastboom MJL; Staals EL; Verspoor FGM; Rueten-Budde AJ; Stacchiotti S; Palmerini E; Schaap GR; Jutte PC; Aston W; Leithner A; Dammerer D; Takeuchi A; Thio Q; Niu X; Wunder JS; van de Sande MAJ;
    J Bone Joint Surg Am; 2019 Jul; 101(14):1309-1318. PubMed ID: 31318811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incomplete resection increases the risk of local recurrence and negatively affects functional outcome in patients with tenosynovial giant cell tumor of the hindfoot.
    Tsukamoto S; Zucchini R; Staals EL; Mavrogenis AF; Akahane M; Palmerini E; Errani C; Tanaka Y
    Foot Ankle Surg; 2020 Oct; 26(7):822-827. PubMed ID: 31839476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study.
    Bernthal NM; Spierenburg G; Healey JH; Palmerini E; Bauer S; ; Gelderblom H; Staals EL; Lopez-Bastida J; Fronk EM; Ye X; Laeis P; van de Sande MAJ
    Orphanet J Rare Dis; 2021 Apr; 16(1):191. PubMed ID: 33926503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of tenosynovial giant cell tumour of the temporomandibular joint: a systematic review.
    Kanbour A; Hurrell M; Ricciardo P
    ANZ J Surg; 2023 Apr; 93(4):869-875. PubMed ID: 37052058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic resection of a localized tenosynovial giant cell tumor causing posterior ankle impingement in a 15-year-old athlete: A case report.
    Yıldırım K; Beyzadeoğlu TB; Pehlivanoğlu T
    Jt Dis Relat Surg; 2021; 32(1):234-238. PubMed ID: 33463443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of surgery in tenosynovial giant cell tumours as measured by patient-reported outcomes on quality of life and joint function.
    Verspoor FGM; Mastboom MJL; Hannink G; van der Graaf WTA; van de Sande MAJ; Schreuder HWB
    Bone Joint J; 2019 Mar; 101-B(3):272-280. PubMed ID: 30813787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: initial experience of molecularly targeted therapy.
    Nakayama R; Jagannathan JP; Ramaiya N; Ferrone ML; Raut CP; Ready JE; Hornick JL; Wagner AJ
    BMC Cancer; 2018 Dec; 18(1):1296. PubMed ID: 30594158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arthroscopic Excision of a Localized Tenosynovial Giant Cell Tumor of the Knee: A Case Report.
    Zmerly H; Draghetti M; Moscato M; Akkawi I
    Curr Rheumatol Rev; 2024; 20(4):459-464. PubMed ID: 38231053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic PPARγ Significantly Correlates With P53 Immunohistochemical Expression and Tumor Size in Localized Tenosynovial Giant Cell Tumor.
    Elkhamisy FAA; Aboelkomsan EA; Sallam MK; Eesa AN
    Cureus; 2024 May; 16(5):e60377. PubMed ID: 38882990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Surgical Treatment for Localized Tenosynovial Giant-Cell Tumor of the Foot and Ankle: A Case Series.
    Ipponi E; Ruinato AD; Lombardi L; Cordoni M; Franco S; D'Arienzo A; Andreani L
    Acta Med Litu; 2023; 30(2):163-170. PubMed ID: 38516519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The surgical outcome and recurrence rate of tenosynovial giant cell tumor in the elbow: a literature review.
    Al Farii H; Zhou S; Turcotte R
    J Shoulder Elbow Surg; 2019 Sep; 28(9):1835-1840. PubMed ID: 31447124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Imatinib Mesylate in diffuse-type Tenosynovial Giant Cell Tumours on MR imaging and PET-CT.
    Mastboom MJL; Lips W; van Langevelde K; Mifsud M; Ng C; McCarthy CL; Athanasou NA; Gibbons CLMH; van de Sande MAJ
    Surg Oncol; 2020 Dec; 35():261-267. PubMed ID: 32932224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment updates on tenosynovial giant cell tumor.
    Palmerini E; Staals EL
    Curr Opin Oncol; 2022 Jul; 34(4):322-327. PubMed ID: 35837703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.